But important limitations exist: Most research is in animals, not humans Long-term safety beyond 12 weeks is uncharacterized Drug interactions haven't been formally studied Cancer relationship remains unclear Who should consider BPC-157: Those researching recovery support for injuries or gut issues Individuals willing to accept calculated risk with an experimental peptide People who can work with a knowledgeable healthcare provider Who should avoid it: Those with active cancer or high cancer risk Anyone on medications that might interact (especially cardiovascular, dopamine-affecting) Individuals unwilling to monitor their response carefully If you choose to use BPC-157, start conservatively (200 mcg daily), use proper injection technique, source from reputable suppliers, and track your body's response
Cloudiness, haziness, or any visible particles are clear signs of contamination
Best Peptide for Tendonitis BPC-157 is commonly associated with tendon healing and is one of the most popular peptides explored for tendon-related concerns
Without progesterone, the womb lining would shed and prevent embryo formation or implantation
Multi-System Reach Beyond the gut, BPC-157 has preclinical evidence across tendons, ligaments, muscles, bone, the liver, and the nervous system
Yet, in the three-plus decades since BPC-157 was discovered, no controlled human trial of the peptide has ever been published